Appel Consulting's Cancer Research Summit-The Future of Cancer Therapeutics.

July 31, 2011 - PRLog -- Join the industry professionals in attendance at the Old Royal Naval College - Greenwich, London, UK on the 11th-12th  October 2011 for a chance to discuss the latest trends and developments in Cancer Research.

New independent evidence confirms that the increasing global trend of unhealthy and sedentary lifestyles is responsible for putting millions at an unnecessarily high risk of cancer.  

New estimates released  by the World Cancer Research Fund (WCRF) global network suggest that across a range of countries, making lifestyle changes including maintaining a healthy weight, eating a healthy diet and taking regular physical activity can reduce the risk of common cancers by up to a third.

These findings are further supported by the World Health Organization’s (WHO) new Global Recommendations on Physical Activity for Health.  This landmark report reinforces that regular physical activity has the potential to prevent many diseases such as breast and colon cancers, cardiovascular diseases and diabetes.

Join us Aug 16-17 at Appel Consulting's  Annual Cancer Research Global Summit.
Network with senior level executives from the top 20 pharmaceutical and biotechnology industries.
Our summit will focus on The Future of Cancer Therapeutics: Accelerating Progress at the Molecular.
Hear updates from industry analysts on, the implementation of new technologies & novel agents.
Why Label Free Biomolecular Analysis for Drug Discovery  could be  beneficial and
key for future breakthroughs. Scientific presentations will provide in-depth
coverage of developing adoptive cellular therapy for Cancer, with sessions dedicated to
pre-clinical models and early stage trials of engineered T cells.

Online registration: http://www.appelconsulting.co.uk/services/products

Speaker Positions still available email sabrina.daw@appelconsulting.co.uk

For brochure request please email charlotte.primrose@appelconsulting.co.uk

For exhibition and sponsorship please email rachel.turner@appelconsulting.co.uk

The conference will focus on main areas of:

1) Future of cancer therapeutics: implementing new technologies & novel agents
2) Cancer stem cells
3) Combining molecularly targeted therapies & chemoradiation
4) Inflammation and cancer
5) Molecular and cellular mechanisms of oncogenesis & tumor suppression
6) public policy issues, ethics & confidentiality

For further information and the opportunity to register online please visit :
http://www.appelconsulting.co.uk/events/cancer-research-1


Appel Consulting is at the forefront of producing the highest quality pharmaceutical events.  All of the events we organise are highly focused towards senior level executives.

Our conferences are all research driven to enable our clients to remain at the cutting edge of business information. Appel Consulting events offer clients key opportunities to network within the pharmaceutical sector.

Sponsorship and exhibition packages provide our clients with a  unique and invaluable platform for business development, within an international community.

For more information kindly email sabrina.daw@appelconsulting.co.uk